Table 2 Clinical characteristics of study participants in TASH oncology center, Ethiopia (n = 1057)
Variables | Code | Early stage | Late stage | ||
|---|---|---|---|---|---|
Frequency | (%) | Frequency | (%) | ||
Comorbidity | Yes | 142 | 41.3 | 202 | 58.7 |
No | 315 | 44.2 | 398 | 55.8 | |
Anemia | Yes | 210 | 38.8 | 331 | 61.2 |
No | 247 | 47.9 | 269 | 52.1 | |
Histology type | Squamous cell | 414 | 43.2 | 545 | 56.8 |
Adenocarcinoma | 43 | 43.9 | 55 | 56.1 | |
HIV status | Negative | 383 | 44.4 | 480 | 55.6 |
Positive | 74 | 38.1 | 120 | 61.9 | |